Debt-to-equity of TITAN PHARMACEUTICALS INC from 31 Mar 2012 to 30 Jun 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
TITAN PHARMACEUTICALS INC quarterly Debt-to-equity in % history and change rate from 31 Mar 2012 to 30 Jun 2025.
  • TITAN PHARMACEUTICALS INC Debt-to-equity for the quarter ending 30 Jun 2025 was 14%, a 21% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

TITAN PHARMACEUTICALS INC Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q2 2025 14% -3% -21% 30 Jun 2025
Q1 2025 13% -16% -55% 31 Mar 2025
Q4 2024 11% -46% -80% 31 Dec 2024
Q3 2024 14% -95% -87% 30 Sep 2024
Q2 2024 17% -256% -94% 30 Jun 2024
Q1 2024 29% -74% -72% 31 Mar 2024
Q4 2023 57% 0% -0.1% 31 Dec 2023
Q3 2023 109% +61% +127% 30 Sep 2023
Q2 2023 273% +235% +609% 30 Jun 2023
Q1 2023 103% +68% +195% 31 Mar 2023
Q4 2022 57% +20% +54% 31 Dec 2022
Q3 2022 48% +3% +7.3% 30 Sep 2022
Q2 2022 39% -55% -59% 30 Jun 2022
Q1 2022 35% -145% -81% 31 Mar 2022
Q4 2021 37% -276% -88% 31 Dec 2021
Q3 2021 45% -406% -90% 30 Sep 2021
Q2 2021 94% -481% -84% 30 Jun 2021
Q1 2021 180% -722% -80% 31 Mar 2021
Q4 2020 313% -2214% -88% 31 Dec 2020
Q3 2020 450% -15% -3.2% 30 Sep 2020
Q2 2020 575% +377% +190% 30 Jun 2020
Q1 2020 902% +703% +354% 31 Mar 2020
Q4 2019 2527% +2275% +899% 31 Dec 2019
Q3 2019 465% -167% -26% 30 Sep 2019
Q2 2019 198% -855% -81% 30 Jun 2019
Q1 2019 199% -15% -7% 31 Mar 2019
Q4 2018 253% +161% +176% 31 Dec 2018
Q3 2018 632% +580% +1108% 30 Sep 2018
Q2 2018 1053% +1014% +2613% 30 Jun 2018
Q1 2018 214% +172% +409% 31 Mar 2018
Q4 2017 92% +38% +69% 31 Dec 2017
Q3 2017 52% -11% -17% 30 Sep 2017
Q2 2017 39% -29% -43% 30 Jun 2017
Q1 2017 42% -104% -71% 31 Mar 2017
Q4 2016 54% -135% -71% 31 Dec 2016
Q3 2016 63% -138% -69% 30 Sep 2016
Q2 2016 68% -199% -75% 30 Jun 2016
Q1 2016 146% -79% -35% 31 Mar 2016
Q4 2015 189% -23% -11% 31 Dec 2015
Q3 2015 201% -48% -19% 30 Sep 2015
Q2 2015 266% -76% -22% 30 Jun 2015
Q1 2015 225% -182% -45% 31 Mar 2015
Q4 2014 213% -952% -82% 31 Dec 2014
Q3 2014 249% +700% 30 Sep 2014
Q2 2014 343% +591% 30 Jun 2014
Q1 2014 407% +598% 31 Mar 2014
Q4 2013 1165% +1320% 31 Dec 2013
Q3 2013 -451% -310% -220% 30 Sep 2013
Q2 2013 -249% -108% -77% 30 Jun 2013
Q1 2013 -191% -48% -34% 31 Mar 2013
Q4 2012 -155% 31 Dec 2012
Q3 2012 -141% 30 Sep 2012
Q2 2012 -141% 30 Jun 2012
Q1 2012 -142% 31 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.